Published in Diabetologia on January 01, 1998
Impaired microvascular perfusion: a consequence of vascular dysfunction and a potential cause of insulin resistance in muscle. Am J Physiol Endocrinol Metab (2008) 1.62
Hypertension in metabolic syndrome: vascular pathophysiology. Int J Hypertens (2013) 0.84
A control systems approach to quantify wall shear stress normalization by flow-mediated dilation in the brachial artery. PLoS One (2015) 0.80
Role of the Renal Microcirculation in Progression of Chronic Kidney Injury in Obesity. Am J Nephrol (2016) 0.76
Microvascular haemodynamic reactions to insulin. J Physiol (2009) 0.75
Policy interventions that attract nurses to rural areas: a multicountry discrete choice experiment. Bull World Health Organ (2010) 2.17
Characterization of plasma unsaturated lysophosphatidylcholines in human and rat. Biochem J (2000) 1.89
Fatty acid substrate specificities of human prostaglandin-endoperoxide H synthase-1 and -2. Formation of 12-hydroxy-(9Z, 13E/Z, 15Z)- octadecatrienoic acids from alpha-linolenic acid. J Biol Chem (1995) 1.45
Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes. Eur J Biochem (1993) 1.38
Acute myocardial infarction in dogs with experimental diabetes. Cardiovasc Res (1993) 1.28
A simple and efficient method for platelet isolation from their plasma. Thromb Res (1980) 1.26
Requirement and role of arachidonic acid in the differentiation of pre-adipose cells. Biochem J (1989) 1.25
Effects of metformin on lactate uptake and gluconeogenesis in the perfused rat liver. Diabetes (1997) 1.20
Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine. J Lipid Res (1999) 1.15
Effects of oxidative stress on adiponectin secretion and lactate production in 3T3-L1 adipocytes. Free Radic Biol Med (2005) 1.15
The phospholipid and fatty acid composition of human platelet surface and intracellular membranes isolated by high voltage free flow electrophoresis. J Biol Chem (1982) 1.12
13-Hydroxyoctadecadienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem (1985) 1.11
Retroconversion and metabolism of [13C]22:6n-3 in humans and rats after intake of a single dose of [13C]22:6n-3-triacylglycerols. Am J Clin Nutr (1996) 1.09
Localisation of phospholipase A2 and diglyceride lipase activities in human platelet intracellular membranes. FEBS Lett (1981) 1.08
Preferential incorporation of sn-2 lysoPC DHA over unesterified DHA in the young rat brain. Am J Physiol (1994) 1.06
Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic Biol Med (1998) 1.05
Reaction of metformin with dicarbonyl compounds. Possible implication in the inhibition of advanced glycation end product formation. Biochem Pharmacol (1999) 1.05
An insulin sensitizer improves the free radical defense system potential and insulin sensitivity in high fructose-fed rats. Diabetes (1999) 1.04
Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells. J Lipid Res (1997) 1.04
The cAMP-specific phosphodiesterase PDE4D3 is regulated by phosphatidic acid binding. Consequences for cAMP signaling pathway and characterization of a phosphatidic acid binding site. J Biol Chem (2000) 1.04
Unsaturated fatty acids esterified in 2-acyl-l-lysophosphatidylcholine bound to albumin are more efficiently taken up by the young rat brain than the unesterified form. J Neurochem (1992) 1.03
Platelets mediate the action of diethylcarbamazine on microfilariae. Nature (1987) 1.02
Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina. Arch Biochem Biophys (1999) 1.01
Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation. FEBS Lett (2009) 1.01
Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus. Thromb Res (1980) 0.99
Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma. Biochem Biophys Res Commun (2005) 0.98
Phosphodiesterase inhibitory profile of some related xanthine derivatives pharmacologically active on the peripheral microcirculation. Biochem Pharmacol (1994) 0.95
Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot Essent Fatty Acids (2006) 0.95
Thrombocytopenia, macrothrombocytopathia, nephritis and deafness. Am J Med (1976) 0.95
The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett (2007) 0.95
Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic Biol Med (1998) 0.92
The formation of tubular structures by endothelial cells is under the control of fibrinolysis and mechanical factors. Angiogenesis (1998) 0.91
Protective effect of docosahexaenoic acid against hydrogen peroxide-induced oxidative stress in human lymphocytes. Biochem Pharmacol (1999) 0.91
Stereospecific inhibition of PGH2-induced platelet aggregation by lipoxygenase products of icosaenoic acids. Biochem Biophys Res Commun (1983) 0.91
12-HETE inhibits the binding of PGH2/TXA2 receptor ligands in human platelets. Thromb Res (1991) 0.90
Docosahexaenoic acid is a major n-3 polyunsaturated fatty acid in bovine retinal microvessels. J Neurochem (1996) 0.90
Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat. Am J Physiol (1996) 0.89
Inhibition of platelet aggregation and thromboxane synthesis after intake of small amount of icosapentaenoic acid. Thromb Res (1984) 0.89
LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia (2011) 0.89
Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids. Adv Exp Med Biol (1985) 0.88
Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents. Mol Pharmacol (1993) 0.88
Action of metformin on erythrocyte membrane fluidity in vitro and in vivo. Eur J Pharmacol (1997) 0.88
Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids (2002) 0.87
Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes. J Mol Cell Cardiol (1996) 0.87
Mitochondrial H2O2 production is reduced with acute and chronic eccentric exercise in rat skeletal muscle. Antioxid Redox Signal (2006) 0.87
Stable isotope tracer and gas-chromatography combustion isotope ratio mass spectrometry to study the in vivo compartmental metabolism of docosahexaenoic acid. Anal Biochem (1994) 0.87
Platelets and aging. I--Aggregation, arachidonate metabolism and antioxidant status. Thromb Res (1988) 0.86
Reversible modifications of neurotransmitters of the brain in experimental acute hepatic coma. Surg Gynecol Obstet (1978) 0.86
Gas chromatographic-mass spectrometric measurement of 15-deoxy-delta(12,14)-prostaglandin J(2), the peroxisome proliferator-activated receptor gamma ligand, in urine. Clin Chem (2001) 0.86
Functional lipidomics of oxidized products from polyunsaturated fatty acids. Chem Phys Lipids (2011) 0.86
Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim Biophys Acta (1982) 0.86
Involvement of type 4 cAMP-phosphodiesterase in the myogenic differentiation of L6 cells. Mol Biol Cell (1999) 0.86
The influence of low intake of n-3 fatty acids on platelets in elderly people. Atherosclerosis (1999) 0.86
DHA metabolism: targeting the brain and lipoxygenation. Mol Neurobiol (2010) 0.86
Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation. Biochem J (1997) 0.86
Effect of the extract of Ginkgo biloba (EGb 761) on the circulating and cellular profiles of polyunsaturated fatty acids: correlation with the anti-oxidant properties of the extract. Prostaglandins Leukot Essent Fatty Acids (2000) 0.86
Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. Diabetes Metab (1997) 0.86
Predictive factors for early mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother (2013) 0.86
Preferential transfer of 2-docosahexaenoyl-1-lysophosphatidylcholine through an in vitro blood-brain barrier over unesterified docosahexaenoic acid. J Neurochem (1999) 0.86
Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients. Diabetologia (2003) 0.85
Specific markers of lipid peroxidation issued from n-3 and n-6 fatty acids. Biochem Soc Trans (2004) 0.85
Metformin improves skin capillary reactivity in normoglycaemic subjects with the metabolic syndrome. Diabet Med (2007) 0.85
Diacylglycerol lipase activity in human platelet intracellular and surface membranes. Some kinetic properties and fatty acid specificity. FEBS Lett (1985) 0.85
In vitro incorporation and metabolism of icosapentaenoic and docosahexaenoic acids in human platelets--effect on aggregation. Thromb Haemost (1986) 0.85
Leukotriene B4 level in stimulated blood neutrophils and alveolar macrophages from healthy and asthmatic subjects. Effect of beta-2 agonist therapy. Eur J Clin Invest (1992) 0.85
The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes. Endocrinology (1996) 0.85
Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans Am Soc Artif Intern Organs (1976) 0.84
Phosphatidic acid stimulates the rolipram-sensitive cyclic nucleotide phosphodiesterase from rat thymocytes. Biochim Biophys Acta (1993) 0.84
Albumin antioxidant capacity is modified by methylglyoxal. Diabetes Metab (2005) 0.84
The acute effect of metformin on glucose production in the conscious dog is primarily attributable to inhibition of glycogenolysis. Metabolism (2000) 0.84
Early increase in lymphocyte cyclic nucleotide phosphodiesterase activity upon mitogenic activation of human peripheral blood mononuclear cells. J Cell Physiol (1992) 0.84
Antibiotics and production of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells in vitro. A comparison of cefodizime and ceftriaxone. Arzneimittelforschung (1994) 0.84
Effects of fatty acids on human platelet glutathione peroxidase: possible role of oxidative stress. Biochem Pharmacol (1997) 0.84
The impaired in vitro production of interleukin-2 in HIV infection is negatively correlated to the number of circulating CD4+DR+ T cells and is reversed by allowing T cells to rest in culture: arguments for in vivo CD4+ T cell activation. Clin Immunol Immunopathol (1993) 0.83
Lipoxygenase activity of intact human platelets. Prostaglandins Leukot Med (1984) 0.83
Effects of insulin and the combination of insulin plus metformin (glucophage) on microvascular reactivity in control and diabetic hamsters. Angiology (1997) 0.83
Selective stimulation of a cAMP-specific phosphodiesterase (PDE4A5) isoform by phosphatidic acid molecular species endogenously formed in rat thymocytes. Eur J Biochem (1997) 0.83
Effects of pyrovalerone on peripheral noradrenergic mechanisms. Biochem Pharmacol (1978) 0.83
Increased intraabdominal adipose tissue mass in fructose fed rats: correction by metformin. Exp Clin Endocrinol Diabetes (2002) 0.83
12(S)-Hydroperoxy-eicosatetraenoic acid increases arachidonic acid availability in collagen-primed platelets. J Lipid Res (2001) 0.83
Memory complaints in the elderly: a study of 367 community-dwelling individuals from 50 to 80 years old. Arch Gerontol Geriatr Suppl (1989) 0.83
[Role of central catecholamines in the psychostimulant activity of pyrovalerone]. Arch Int Pharmacodyn Ther (1976) 0.83
Physiological and morphometric analysis of the microcirculation of the cerebral cortex under acute vasospasm. Stroke (1982) 0.83
Docosapentaenoic acid (22:5,n-3): metabolism and effect on prostacyclin production in endothelial cells. Prostaglandins Leukot Essent Fatty Acids (1996) 0.82
Inhibition of the different phosphodiesterase isoforms of rat heart cytosol by free fatty acids. J Cardiovasc Pharmacol (1993) 0.82
Age-related changes in antioxidant defence mechanisms and peroxidation in isolated hepatocytes from spontaneously hypertensive and normotensive rats. Mol Cell Biochem (1994) 0.82
Involvement of calcium-independent phospholipase A2 in uterine stromal cell phospholipid remodelling. Eur J Biochem (2000) 0.82
Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets. Prostaglandins (1992) 0.82
Incorporation and turnover of eicosapentaenoic and docosahexaenoic acids in human blood platelets in vitro. Biochem J (1992) 0.82
Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2. J Leukoc Biol (2000) 0.82
Characterization of A-2 receptors in postmortem human pineal gland. J Neurochem (1990) 0.81
Arachidonic acid up-regulates and prostaglandin E2 down-regulates the expression of pancreatic-type phospholipase A2 and prostaglandin-endoperoxide synthase 2 in uterine stromal cells. Eur J Biochem (1996) 0.81
Incomplete transient ischemia: a non-destructive evaluation of in vivo cerebral metabolism and hemodynamics in rat brain. Stroke (1982) 0.81